What is the current stock price of Delivra Health Brands Inc. (DHBUF)?

As of the latest market data, Delivra Health Brands Inc. (DHBUF) is trading at $0.11. The stock has seen a loss of -1.90% today.

Does Delivra Health Brands Inc. (DHBUF) pay a dividend?

Based on current data, Delivra Health Brands Inc. does not have a confirmed active dividend policy.

What is the market cap of Delivra Health Brands Inc.?

The current market capitalization of Delivra Health Brands Inc. (DHBUF) is approximately unavailable.

DHBUF

Delivra Health Brands Inc.·Healthcare

0.11

1.899%(−0.00)

Market Closed

0.12

11.521%(+0.01)

After Hours

Last Updated: — ET

52W L: $0.0652W H: $0.26

DHBUF NEWS

proactiveinvestors.com

Mar 27

Delivra Health targets kids sleep market growth – ICYMI

Delivra Health Brands Inc. (TSX-V:DHB, OTCQB:DHBUF, FRA:3F0) CEO Gord Davey talked with Proactive about the upcoming launch of DreamWater Kids Sleep Gummies...

Company Profile

Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. It is involved in selling of cannabis, liquid sleep shots, sleep powder packets, and pain relief creams. The company is headquartered in Vancouver, Canada.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

IPO Date

2017-05-02

Beta

0.80

Websitedelivrahealthbrands.com↗

proactiveinvestors.com

Mar 23

Lindian brings Kangankunde closer to production with Tipume camp milestone

Lindian Resources Ltd (ASX:LIN, OTC:LINIF) has marked a key step forward at its flagship Kangankunde rare earths project in Malawi, bringing its on-site...

DHBUF

Delivra Health targets kids sleep market growth – ICYMI

Delivra Health targets kids sleep market growth – ICYMI

Lindian brings Kangankunde closer to production with Tipume camp milestone

Delivra Health to launch Kids Sleep Gummies in US in June

Super Micro Computer stock tumbles after co-founder charged in Nvidia GPU smuggling case

Delivra Health Brands Launches Dream Water(R) Kids Sleep Gummies in the United States Market

Veradermics eyes FDA first as Jefferies initiates at 'buy'; sees 75% upside on oral hair loss pill